KRAS and non-small cell lung carcinoma: We employed five NSCLC PDX models with distinct genotypes: the MT-101 and MT-102 models harbor concurrent mutant KEAP1/KRAS, while the WT-201, WT-202 and WT-203 models exhibit KEAP1/KRAS WT (Supplementary Table 3).